| Literature DB >> 29721549 |
Megan E Kauffman1, Melinda K Kauffman2, Kassim Traore1, Hong Zhu1, Michael A Trush3, Zhenquan Jia4, Y Robert Li1,4,5,6.
Abstract
MitoSOX-based assays are widely used to detect mitochondrial reactive oxygen species (ROS), especially superoxide. To this end, 5 μM MitoSOX is commonly used. In this ROS Protocols article, we described the flow cytometric protocol involving the use of various concentrations of MitoSOX (1, 2.5, 5 μM) for detecting mitochondrial ROS in control and mitochondrial DNA-deficient (MD) melanoma B16-F10 cells. We also compared the MitoSOX-based flow cytometry with lucigenin-derived chemiluminometry for their ability to reliably detect the relative differences in mitochondrial ROS formation in the control and MD cells. Our results suggested that 1 μM, rather than the commonly used 5 μM, appeared to be the optimal concentration of MitoSOX for detecting mitochondrial ROS via flow cytometry.Entities:
Keywords: B16-F10 melanoma cells; Chemiluminometry; Flow cytometry; MitoSOX; Mitochondrial DNA-deficient cells; Mitochondrial ROS
Year: 2016 PMID: 29721549 PMCID: PMC5926237 DOI: 10.20455/ros.2016.865
Source DB: PubMed Journal: React Oxyg Species (Apex)